Literature DB >> 4866097

Host-parasite relationships among group A streptococci. IV. Suppression of antibody response by streptococcal pyrogenic exotoxin.

E E Hanna, D W Watson.   

Abstract

In rabbits, purified streptococcal pyrogenic exotoxin, at 0.002 of the ld(50) dose, suppressed the antibody response to injected sheep erythrocytes. The antibody suppressed was determined by density gradient ultracentrifugal analysis to be of the 19S class. Background serum antibody (50% hemolytic units), as determined photometrically, correlated well with background antibody-forming spleen cells, as determined by the hemolytic-plaque technique. The exotoxin induced neither positive nor negative changes in background antibody levels, but suppressed the early secondary response to injected antigen. A comparison and control experiment showed that purified gram-negative bacterial endotoxin at identical protocol did not induce antibody suppression, but did induce the well-known adjuvant effect. Because streptococcal pyrogenic exotoxin is known to inhibit the phagocytic function of the reticuloendothelial system (RES), these data strongly support the concept that antigen is processed by cells of the RES before it evokes a secondary immune response. The results also demonstrated that streptococcal pyrogenic exotoxin may play a unique role in lowering the acquired defense of the host against infection. If the anamnestic immune response of the host is temporarily suppressed, then the host-parasite balance would be upset in favor of the parasite.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4866097      PMCID: PMC251965          DOI: 10.1128/jb.95.1.14-21.1968

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  24 in total

1.  STUDIES ON THE ADJUVANT ACTION OF BACTERIAL ENDOTOXINS ON ANTIBODY FORMATION. V. THE INFLUENCE OF ENDOTOXIN AND 5-FLUORO-2-DEOXYURIDINE ON THE PRIMARY ANTIBODY RESPONSE OF THE BALB MOUSE TO A PURIFIED PROTEIN ANTIGEN.

Authors:  K MERRITT; A G JOHNSON
Journal:  J Immunol       Date:  1963-08       Impact factor: 5.422

2.  The serum hemolysin response in intact and splenectomized rabbits following immunization by various routes.

Authors:  L R DRAPER; D H SUSSDORF
Journal:  J Infect Dis       Date:  1957 Mar-Apr       Impact factor: 5.226

3.  The effect of splenectomy on the formation of circulating antibody in the adult male albino rat.

Authors:  D A ROWLEY
Journal:  J Immunol       Date:  1950-04       Impact factor: 5.422

4.  Use of an antiglobulin serum to detect cells producing antibody with low haemolytic efficiency.

Authors:  D W Dresser; D H Wortis
Journal:  Nature       Date:  1965-11-27       Impact factor: 49.962

Review 5.  Suppression of immunologic responses.

Authors:  T Makinodan; J F Albright; E H Perkins; P Nettesheim
Journal:  Med Clin North Am       Date:  1965-11       Impact factor: 5.456

6.  Ontogeny of the immune response. IV. The role of antigen elimination in the true primary immune response in germfree, colostrum-deprived piglets.

Authors:  Y B Kim; S G Bradley; D W Watson
Journal:  J Immunol       Date:  1967-08       Impact factor: 5.422

7.  The differentiation of three distinct desoxyrlbonucleases of group A Streptococci.

Authors:  L W WANNAMAKER
Journal:  J Exp Med       Date:  1958-06-01       Impact factor: 14.307

8.  Hypertrophy versus hyperplasia.

Authors:  R J Goss
Journal:  Science       Date:  1966-09-30       Impact factor: 47.728

9.  MODIFICATION OF HOST RESPONSES TO BACTERIAL ENDOTOXINS. I. SPECIFICITY OF PYROGENIC TOLERANCE AND THE ROLE OF HYPERSENSITIVITY IN PYROGENICITY, LETHALITY, AND SKIN REACTIVITY.

Authors:  D W WATSON; Y B KIM
Journal:  J Exp Med       Date:  1963-09-01       Impact factor: 14.307

10.  Antibody formation in vitro.

Authors:  M FISHMAN
Journal:  J Exp Med       Date:  1961-12-01       Impact factor: 14.307

View more
  27 in total

Review 1.  Suppression of the immune response by microorganisms.

Authors:  J H Schwab
Journal:  Bacteriol Rev       Date:  1975-06

2.  Male sex predominance in Chlamydia trachomatis sexually acquired reactive arthritis: are women more protected by anti-chlamydia antibodies?

Authors:  S Bas; C Scieux; T L Vischer
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

3.  Heterogeneity of group A streptococcal pyrogenic exotoxin type B.

Authors:  E L Barsumian; C M Cunningham; P M Schlievert; D W Watson
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

4.  Alteration of clearance function by group A streptococcal pyrogenic exotoxin and its relation to suppression of the antibody response.

Authors:  C M Cunningham; D W Watson
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

5.  Purification and characterization of group A streptococcal pyrogenic exotoxin type C.

Authors:  P M Schlievert; K M Bettin; D W Watson
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

6.  Suppression of adjuvant disease by bacterial extracellular products.

Authors:  F Quagliata; A Taranta
Journal:  Ann Rheum Dis       Date:  1972-11       Impact factor: 19.103

7.  The gene for type A streptococcal exotoxin (erythrogenic toxin) is located in bacteriophage T12.

Authors:  C R Weeks; J J Ferretti
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

8.  Suppression of antibody response by group A streptococcal pyrogenic exotoxin and characterization of the cells involved.

Authors:  C M Cunningham; D W Watson
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

9.  Further purification of group A streptococcal pyrogenic exotoxin and characterization of the purified toxin.

Authors:  C M Cunningham; E L Barsumian; D W Watson
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

10.  Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome.

Authors:  D F Talkington; B Schwartz; C M Black; J K Todd; J Elliott; R F Breiman; R R Facklam
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.